Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Researchers Find Risk Markers for… >
Researchers Find Risk Markers for Erectile Dysfunction Following Radiation in Prostate Cancer

Published: September 27, 2012.
By The Mount Sinai Hospital / Mount Sinai School of Medicine
http://www.mountsinai.org

In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation. The findings, to be published online September 27, 2012, in advance of the October 1, 2012 print issue in the International Journal of Radiation Oncology• Biology• Physics, the official scientific journal of the American Society for Radiation Oncology, are an important step towards helping clinicians determine the best course of treatment for prostate cancer patients and may lead to the development of therapies that alleviate side effects.

The main treatments for prostate cancer – surgery, brachytherapy (seed implants) and external beam radiation therapy – are all very effective at curing prostate cancer. Unfortunately, each treatment places patients at risk for ED. According to the National Cancer Institute, the prevalence of erectile dysfunction following external beam radiation for prostate cancer ranges from 65 percent to 85 percent. The Prostate Cancer Foundation estimates prevalence of ED following seed therapy at 25 to 50 percent. Many men will be able to regain their potency with time and treatments, but doctors would like to identify which men may be more likely to develop this side effect.

In the first large scale Genome-Wide Association Study to identify single nucleotide polymorphisms (SNPs) associated with susceptibility for the development of erectile dysfunction following radiotherapy for prostate cancer, researchers conducted a two-part study, first, to discover the candidate genetic markers of side effect risk, and second, to confirm which of those markers are replicated in a second group of patients. In the first group of prostate cancer patients, which included 132 men who developed erectile dysfunction after radiotherapy and 103 men similarly treated who did not develop erectile dysfunction, they found a set of genetic markers associated with erectile dysfunction. In the second part of the study, which examined 128 patients who developed erectile dysfunction after radiotherapy and 102 who did not, researchers confirmed that 12 SNPs were associated with erectile dysfunction.

"Thankfully, current treatments for prostate cancer offer excellent rates of long-term survival, so patients and their physicians have a choice about which treatment path to take," said Barry Rosenstein, PhD, Professor of Radiation Oncology, Mount Sinai School of Medicine. "However, the risk of developing erectile dysfunction after radiation treatment is highly variable, suggesting there may be a genetic component to determining that risk. Our study confirms that specific markers make certain patients more susceptible to this side effect."

Patients in the study cohort were given one of three treatments: internal radiotherapy, known as brachytherapy; brachytherapy plus external beam radiation; or external beam radiation alone. They were followed for an average length of nearly four years to determine level of sexual function after treatment.

Interestingly, the 12 SNPs identified in this study were located near genes that seem to be related to erectile function rather than related to radiation response. The researchers conclude that these SNPs may affect genes that sensitize a patient to developing erectile dysfunction when exposed to radiation during therapy.

"Prostate cancer screening and treatment are undergoing major shifts," said Harry Ostrer, MD, Professor of Pathology and Genetics at Albert Einstein College of Medicine and Director of Genetic and Genomic Testing at Montefiore Medical Center and co-principal investigator of the study. "This is part of our ongoing effort to identify men at highest risk for disease, identify the aggressive tumors that would be responsive to therapy, and to improve quality of life for men with indolent prostate cancers who might benefit from active surveillance, rather than therapy."

The authors indicate that examination of a large, independent cohort of similarly treated patients will be necessary to definitively determine which SNPs to include as part of a clinically useful predictive test to identify which men are at greatest risk for developing erectile dysfunction following prostate cancer radiotherapy. The researchers are also evaluating the impact of radiation treatment on urinary complications and proctitis, the inflammation of the rectum.




Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Cancer 
10/25/10 
Adding Radiation to Hormone Therapy for Prostate Cancer Treatment Will Increase Survival Chances
By American Society for Radiation Oncology
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, …
Men 
7/26/11 
Hormone Therapy May Be Hazardous for Men with Heart Conditions
By American Society for Radiation Oncology
Fairfax, Va., July 26, 2011 – Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk …
Therapy 
2/1/12 
Research from the 2012 Genitourinary Cancers Symposium Highlights New Treatments, Compares Existing Therapies for Prostate Cancer
By American Society of Clinical Oncology
Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer were released today, in advance of the fourth annual Genitourinary Cancers Symposium, …
Cancer 
9/27/12 
Predicting Erectile Dysfunction from Prostate Cancer Treatment
By American Society for Radiation Oncology
Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in …
Treatment 
5/13/14 
Older, Sicker Men with Early-stage Prostate Cancer Do Not Benefit from Aggressive Treatment
By University of California - Los Angeles Health Sciences
Treating older men with early-stage prostate cancer who also have other serious underlying health problems with aggressive therapies such as surgery or radiation therapy does not help them live …
Men 
3/17/14 
Primary Androgen Deprivation Therapy Ineffective for Most Men with Early Prostate Cancer
By Georgetown University Medical Center
WASHINGTON — A study of more than 15,000 men with early stage prostate cancer finds that those who received androgen deprivation as their primary treatment instead of surgery or …
Age 
12/21/10 
Age Plays Too Big a Role in Prostate Cancer Treatment Decisions
By University of California - San Francisco
Older men with high-risk prostate cancer frequently are offered fewer – and less effective – choices of treatment than younger men, potentially resulting in earlier deaths, according to a …
High-Risk 
2/12/13 
Research from the 2013 Genitourinary Cancers Symposium Highlights New Insights on High-risk Prostate Cancer Prevalence And Treatment, Compares Benefit of Surveillance And Surgery for Management of Small Kidney Tumors
By American Society of Clinical Oncology
ALEXANDRIA, Va. – Research on promising new therapies and data on the relative benefits of established treatments for genitourinary cancers were released today, in advance of the fourth annual …
Rectal 
5/30/14 
Radiation for Prostate Cancer Linked to Secondary Cancers, Study Finds
By University of Michigan Health System
ANN ARBOR, Mich. — Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study …
Prostate 
1/4/13 
How Prostate Cancer Therapies Compare by Cost And Effectiveness
By University of California - San Francisco
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness …
Men 
9/20/11 
Candid Discussion Regarding Sexuality Can Improve Quality of Life for Prostate Cancer Survivors
By Beth Israel Deaconess Medical Center
BOSTON – Physicians are now better able to predict a man's recovery of sexual function after prostate cancer treatment, making a conversation between doctor and patient an important part …
Radiation 
4/1/14 
Medication Does Not Help Prevent ED Following Radiation Therapy for Prostate Cancer
By The JAMA Network Journals
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a …
Prostate 
3/15/13 
Surgery Is Superior to Radiotherapy in Men with Localized PCa, Says Prize-winning Swedish Study
By European Association of Urology
Arnhem, 11 March 2013 - Surgery offers better survival benefit for men with localised prostate cancer, according to a large observational study, conducted by a group of researchers in …
Cancer 
6/1/10 
Patients Who Refuse Prostate Cancer Surgery Have Worse Long-term Survival
By Henry Ford Health System
DETROIT – Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" – monitoring cancer progression without undergoing treatment – have a significantly worse long-term survival …
Treatment 
1/2/13 
Some Men Voice Complaints of Shortened Penis Following Prostate Cancer Treatment
By Dana-Farber Cancer Institute
BOSTON – A small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, with some saying that it interfered with intimate relationships …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition